InspackBook a demo
Compounding pharmacies and 503B facilities

Catch label errors before your next inspection

Inspack checks every label, container and insert against 503B requirements and your SOPs, across every site, in minutes.

503B batch and container labels with a missing statement, strength mismatch and missing BUD flagged

01 / The problem

Label errors still show up in warning letters

01

Required statements go missing

Recent FDA letters still cite missing items like “This is a compounded drug” and the established name.

02

Documents drift apart

Label, container and insert disagree on strength, ingredients, BUD or storage.

03

Every site does it differently

Label templates and checks vary from one pharmacy or facility to the next.

04

Proof is scattered

When a board inspector or FDA investigator asks what was reviewed, the answer lives in inboxes.

Every label checked the same way, at every site

What we check

  • Patient-specific and batch labels
  • Container labels and outer packaging
  • Inserts and directions for use
  • Active and inactive ingredients
  • BUD, lot and storage statements
  • “Office use only” and “Not for resale”

Against what

  • 503B labeling requirementsevery product
  • Your label templates and SOPsturned into checks
  • State pharmacy board rulesby state you ship to

Every issue comes with

  • the rule behind it
  • a suggested fix
  • a full audit trail

02 / How it works

From label template to QA release

01Upload

Add a label set

Upload the label, container and insert for one product. Pick your rules or use the ones we suggest.

Label set, Facility B3 files added
  • Batch labelMethylcobalamin 1,000 mcg/mL injection
    Added
  • Container label10 mL multi-dose vial
    Added
  • InsertDirections for use
    Added
02Review

See every finding

Missing statements and mismatches across documents, each with the rule behind it.

Findings3 open
  • “Not for resale” missingFDCA 503B(a)(10) · label
    Issue
  • Container strength differs from batch labelCross-document check
    Issue
  • BUD missing from container labelYour SOP · BUD rule
    Issue
03Release

Release with a record

QA signs off before labels print. Every review is logged and ready for your next inspection.

03 / The difference

Label review, with and without Inspack

TodayWith Inspack
Labels checked by eyeEvery product checked against the rules
Mismatches found after printingCaught before labels print
Each site follows its own processOne ruleset across every site
New formulations wait for QAFirst pass in minutes
Proof lives in email threadsOne review record per product

Get a free label check

Send us three label sets: label, container and insert. We return every finding with the rule behind it.

04 / FAQ

Compounded drug labeling, answered

Yes. 503B labels are checked against the statutory label requirements. For 503A, upload your label templates and SOPs, including your BUD rules, and Inspack turns them into checks.

Yes. Set your rules once and every site reviews against the same checks.

Yes. Check corrected labels before they print, and keep new formulations from repeating the same findings.

No. Inspack is the first pass, so QA and your pharmacist in charge only spend time on real findings. It doesn’t give legal advice.

No. Inspack reviews label content. It doesn’t assess CGMP, sterile or non-sterile compounding practices.

No. We review label content, not prescriptions or patient records.